Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

29452 ARTÍCULOS , VIENDO DEL 1591 AL 1605

Consensus statement on the use of Alzheimer's disease biomarkers and anti-amyloid therapies in Hong Kong

Shum CK, Shea YF, Au Yeung TW, Chan CCY, Chan WC, Cheng WK, Cheung NYF, Cho DHY, Chow TK, Fong GCY, Ip BYM, Kwok JSH, Lai BMH, Lam LCW, Lee ATC, Lok CM, Mok KY, Ng DKK, Siu DYW, Yeung PY, Tam SKF.

Hong Kong Med J. 2026 Apr;32(2):144-154. doi: 10.12809/hkmj2514198. Epub 2026 Apr 13.

FDA-Approved Passive Immunization Treatments Against Aβ in Alzheimer's Disease: Where Are We Now?

Higgins M, Wasef V, Kwakowsky A.

Int J Mol Sci. 2026 Jan 15;27(2):883. doi: 10.3390/ijms27020883.

Etalanetug (E2814) in dominantly inherited Alzheimer's disease: an open-label phase 1b/2 study to assess safety and target engagement in participants with mild to moderate cognitive impairment

Andreozzi E, Yagi T, Wildsmith K, Rawal S, Horie K, Boyd P, Takahashi E, Barthélemy NR, Aluri J, Charil A, Reilhac A, Gordon BA, Flores S, Verbel D, Sauter N, Benzinger TLS, McDade E, Mummery C; Dominantly Inherited Alzheimer Network (DIAN); Dominantly Inherited Alzheimer Network Trials Unit (DIAN-TU); Zhou J, Bateman RJ, Reyderman L.

Alzheimers Res Ther. 2026 Apr 10;18(1):87. doi: 10.1186/s13195-026-02047-y.

[Alzheimer's disease and other neurocognitive disorders - epidemiology and new diagnostic criteria]

Borgh Skillbäck T, Palmqvist S, Eriksdotter M, Skoog I, Kern S.

Lakartidningen. 2026 May 19;123:25140.

Dual-model deep learning for Alzheimer's prognostication

Fin S, Moayedikia A, Wiil UK.

Comput Biol Med. 2026 May 15;208:111672. doi: 10.1016/j.compbiomed.2026.111672. Epub 2026 Apr 9.

Randomization to hormone therapy and changes in plasma biomarkers of Alzheimer's pathology: The women's health initiative memory study

Shadyab AH, Zhang B, LaCroix AZ, McEvoy LK.

Maturitas. 2026 Apr;207:108873. doi: 10.1016/j.maturitas.2026.108873. Epub 2026 Feb 11.

Digital biomarkers in early Alzheimer's disease from wearable or portable technology: A scoping review

Gramkow MH, Gleerup HSC, Simonsen AH, Waldemar G, Frederiksen KS.

J Neurol Sci. 2026 Feb 15;481:125734. doi: 10.1016/j.jns.2026.125734. Epub 2026 Jan 6.

Diagnostic performance of salivary markers of Alzheimer's disease: A systematic review

Borelli PV, Machado L, Carello-Collar G, Ferreira PCL, Lourenço de Lima AMD, Bellaver B, Pascoal TA, Benedet AL, Ashton NJ, Zimmer ER, Borelli WV.

Alzheimers Dement. 2026 Apr;22(4):e71248. doi: 10.1002/alz.71248.

Integration over reduction: multimodal PET and fluid biomarkers in Alzheimer's disease and beyond

Bluma M, Chiotis K, Nordberg A.

Curr Opin Neurol. 2026 Apr 1;39(2):176-184. doi: 10.1097/WCO.0000000000001462. Epub 2026 Feb 23.

Advances in ultrasensitive detection technologies for blood-based biomarkers of Alzheimer's disease

Mou Y, Sun C, Deng K, Lin F, Yang Z, Wang Y, Deng X, Yang F, Hu X, Jiang Q.

J Mater Chem B. 2026 Apr 29;14(16):4848-4873. doi: 10.1039/d5tb02633d.

Therapeutic Landscape of Early Symptomatic Alzheimer's Disease Translated into Everyday Practice for Geriatric Providers

Bailey-Taylor MJ, Morrow P, Hendrix J, Galluzzi KE, Sharafsaleh G.

Clin Interv Aging. 2026 May 12;21:585263. doi: 10.2147/CIA.S585263. eCollection 2026.

Associations of cortisol with Alzheimer's disease fluid and neuroimaging biomarkers: A systematic review

Holleman J, Toopchiani S, Robinson O, Kåreholt I, Kivipelto M, Middleton L, Solomon A, Udeh-Momoh CT, Sindi S.

Front Neuroendocrinol. 2026 Apr;81:101246. doi: 10.1016/j.yfrne.2026.101246. Epub 2026 Mar 17.

Effect of a Nutraceutical Combination on Oxidative Stress Biomarkers in Healthy Subjects and Patients with Alzheimer's Disease

Jastrząb R, Małecki A, Kmiecik-Małecka E, Gorzkowska A, Kubas K, Widłak-Kargul J, Wolman D, Matkiewicz K, Nowacka-Chmielewska M, Liśkiewicz D, Grabowska K, Grabowski M, Pondel N, Początek G, Kłodowska G, Mytych J.

Nutrients. 2026 Feb 27;18(5):789. doi: 10.3390/nu18050789.

A path to preventing cognitive impairment due to Alzheimer's disease: initiatives beginning in the USA

Reiman EM, Alexander RC, Langbaum JB, Aisen PS, Ashton N, Atri A, Barbarino P, Byrd GS, Feldman HH, Fowler NR, Ghisays V, Grill JD, Hassenstab J, Heaton GR, Herring WL, Jack CR Jr, Johnson SC, Karlawish J, Keach NL, Kivipelto M, Krumholz HM, Largent EA, MaGee-Rodgers T, McDade E, Mielke MM, Molina-Henry D, Petersen RC, Rabinovici GD, Ritchie C, Schindler SE, Sperling RA, Suárez-Calvet M, Vradenburg G, Weiner MW, Welsh-Bohmer KA, Zetterberg H, Zuendel MT, Mattke S, Cummings JL.

Lancet Neurol. 2026 Mar;25(3):268-278. doi: 10.1016/S1474-4422(25)00483-1.

Oxidative stress biomarkers and flavonoids in Alzheimer's disease: current clinical evidence and therapeutic perspectives

Zainuddin MS, Pamidi N, Azman AS, Bai Magalingam K, Bhuvanendran S.

Redox Rep. 2026 Dec 31;31(1):2677396. doi: 10.1080/13510002.2026.2677396. Epub 2026 May 26.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias